ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000262652.1	AKT inhibitor VIII	Bladder urothelial carcinoma	0.023781925	Resistant
ENSG00000262652.1	AKT inhibitor VIII	Lung squamous cell carcinoma	0.003753199	Resistant